Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBeOne Medicines Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.96 | -$0.36 | -$0.57 |
| Q2 2025 | 7 | -$0.12 | $1.17 | $0.39 |
| Q3 2025 | 6 | $0.77 | $1.02 | $0.85 |
| Q4 2025 | 6 | $1.41 | $1.59 | $1.50 |
| Q1 2026 | 2 | $0.56 | $0.59 | $0.57 |
| Q2 2026 | 1 | $1.16 | $1.22 | $1.19 |
| Q3 2026 | 1 | $1.32 | $1.39 | $1.36 |
| Q4 2026 | 1 | $1.65 | $1.74 | $1.70 |
| Q1 2027 | 1 | $2.05 | $2.16 | $2.11 |
| Q2 2027 | 1 | $2.20 | $2.32 | $2.27 |
| Q3 2027 | 1 | $2.25 | $2.37 | $2.32 |
| Q4 2027 | 1 | $2.51 | $2.65 | $2.59 |
BeOne Medicines Ltd. Earnings Date And Information
BeOne Medicines Ltd. last posted its earnings results on Thursday, November 6th, 2025. The company reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.72 by $0.37. The company had revenue of 1.41 B for the quarter and had revenue of 3.81 B for the year. BeOne Medicines Ltd. has generated $-6 earnings per share over the last year ($-6.12 diluted earnings per share) and currently has a price-to-earnings ratio of -21.31. BeOne Medicines Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 26th, 2026 based on prior year's report dates.
BeOne Medicines Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | $0.72 | $14.69 | 13.97 | $1.37 B | $1.41 B |
| 08/06/2025 | Q2 2025 | $0.48 | $0.87 | 0.39 | $1.24 B | $1.32 B |
| 03/31/2025 | Q1 2025 | N/A | $0.01 | N/A | N/A | $1.12 B |
| 12/31/2024 | Q4 2024 | N/A | -$1.43 | N/A | N/A | $1.13 B |
| 09/30/2024 | Q3 2024 | N/A | -$1.16 | N/A | $983.26 M | $1.00 B |
| 06/29/2024 | Q2 2024 | N/A | -$1.15 | N/A | $810.34 M | $929.17 M |
| 03/30/2024 | Q1 2024 | N/A | -$2.47 | N/A | N/A | $751.65 M |
| 12/30/2023 | Q4 2023 | N/A | -$25.48 | N/A | N/A | $634.41 M |
| 09/29/2023 | Q3 2023 | N/A | $2.08 | N/A | N/A | $781.31 M |
| 06/29/2023 | Q2 2023 | N/A | -$3.64 | N/A | N/A | $595.26 M |
| 03/31/2023 | Q1 2023 | N/A | -$3.38 | N/A | N/A | $447.80 M |
| 12/30/2022 | Q4 2022 | N/A | -$30.55 | N/A | N/A | $380.10 M |
| 09/29/2022 | Q3 2022 | N/A | -$5.33 | N/A | N/A | $387.63 M |
| 06/29/2022 | Q2 2022 | N/A | -$5.59 | N/A | N/A | $341.57 M |
| 03/30/2022 | Q1 2022 | N/A | -$4.29 | N/A | N/A | $306.63 M |
| 12/30/2021 | Q4 2021 | N/A | -$6.11 | N/A | N/A | $213.98 M |
| 09/29/2021 | Q3 2021 | N/A | -$4.42 | N/A | N/A | $206.44 M |
| 06/29/2021 | Q2 2021 | N/A | -$5.20 | N/A | N/A | $149.99 M |
| 03/30/2021 | Q1 2021 | N/A | $0.78 | N/A | N/A | $605.87 M |
| 12/30/2020 | Q4 2020 | N/A | -$5.20 | N/A | N/A | $100.10 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BeOne Medicines Ltd. Earnings: FAQ's
BeOne Medicines Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 26th, 2026 based offlast year's report dates.
In the previous quarter, BeOne Medicines Ltd. (:ONC) reported $1.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.72 by $0.37.
The conference call for BeOne Medicines Ltd.'s latest earnings report can be listened to online.
The conference call transcript for BeOne Medicines Ltd.'s latest earnings report can be read online.
BeOne Medicines Ltd. (:ONC) has a recorded annual revenue of $3.81 B.
BeOne Medicines Ltd. (:ONC) has a recorded net income of $-644,786,000.BeOne Medicines Ltd. has generated $-6.12 earnings per share over the last four quarters.
BeOne Medicines Ltd. (:ONC) has a price-to-earnings ratio of -21.31 and price/earnings-to-growth ratio is -0.11.